Crown Electrokinetics Corp. Common Stock
CRKN
CRKN was delisted on the 4th of March, 2025.
1 hedge funds and large institutions have $4.56M invested in Crown Electrokinetics Corp. Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
44% less capital invested
Capital invested by funds: $8.13M → $4.56M (-$3.57M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HWM
Hohimer Wealth Management
Seattle,
Washington
|
-$284K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$98K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$18K |
CRKN Hedge Fund Activity: Q1 2022 in Review
1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Crown Electrokinetics Corp. Common Stock (CRKN) for Q1 2022, worth a combined $4.56M — down 44% from $8.13M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CRKN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $3.1M. The largest seller was Hohimer Wealth Management, cutting an estimated $284K.
- 1 institutional investor held Crown Electrokinetics Corp. Common Stock (CRKN) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $4.56M of Crown Electrokinetics Corp. Common Stock stock for Q1 2022, down 44% quarter-over-quarter.
- 1 fund opened new Crown Electrokinetics Corp. Common Stock positions in Q1 2022 and 0 closed out, a net change of +1 holder.
- The largest Crown Electrokinetics Corp. Common Stock buyer in Q1 2022 was Vanguard Group, an estimated $3.1M added.
- The largest Crown Electrokinetics Corp. Common Stock seller in Q1 2022 was Hohimer Wealth Management, an estimated $284K sold.
Based on aggregated 13F filings for Q1 2022.